Warren, Stephen T.

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome

Gross, C., Nakamoto, M., Yao, X., Chan, C.-B., Yim, S. Y., Ye, K., Warren, S. T., & Bassell, G. J. (2010) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 241

FMRP Phosphorylation Reveals an Immediate-Early Signaling Pathway Triggered by Group I mGluR and Mediated by PP2A

Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2007) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 228

Genome‐wide association study of schizophrenia in Ashkenazi Jews

Goes, F. S., McGrath, J., Avramopoulos, D., Wolyniec, P., Pirooznia, M., Ruczinski, I., Nestadt, G., Kenny, E. E., Vacic, V., Peters, I., et al. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 226

Microdeletions of 3q29 confer high risk for schizophrenia

Mulle, J. G., Dodd, A. F., McGrath, J. A., Wolyniec, P. S., Mitchell, A. A., Shetty, A. C., Sobreira, N. L., Valle, D., Rudd, M. K., Satten, G., et al. (2010) · The American Journal of Human Genetics

Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment

Cited by 223

S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade

Narayanan, U., Nalavadi, V., Nakamoto, M., Thomas, G., Ceman, S., Bassell, G. J., & Warren, S. T. (2008) · Journal of Biological Chemistry

Genetics and Neurodevelopmental DisordersPI3K/AKT/mTOR signaling in cancer

Cited by 216

Characterization of the full fragile X syndrome mutation in fetal gametes

Malter, H. E., Iber, J. C., Willemsen, R., Graaff, E. D., Tarleton, J. C., Leisti, J., Warren, S. T., & Oostra, B. A. (1997) · Nature Genetics

Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases

Cited by 197

Isolation of an FMRP-Associated Messenger Ribonucleoprotein Particle and Identification of Nucleolin and the Fragile X-Related Proteins as Components of the Complex

Ceman, S., Brown, V., & Warren, S. T. (1999) · Molecular and Cellular Biology

Genetics and Neurodevelopmental DisordersRNA Research and Splicing

Cited by 181

Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures

Myrick, L. K., Deng, P.-Y., Hashimoto, H., Oh, Y. M., Cho, Y., Poidevin, M. J., Suhl, J. A., Visootsak, J., Cavalli, V., Jin, P., et al. (2015) · Proceedings of the National Academy of Sciences

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 133

New perspectives on the biology of fragile X syndrome

Wang, T., Bray, S. M., & Warren, S. T. (2012) · Current Opinion in Genetics & Development

Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases

Cited by 116

A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium

Gur, R. E., Bassett, A. S., McDonald-McGinn, D. M., Bearden, C. E., Chow, E., Emanuel, B. S., Owen, M., Swillen, A., Van den Bree, M., Vermeesch, J., et al. (2017) · Molecular Psychiatry

Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment

Cited by 93

Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences

Suhl, J. A., Chopra, P., Anderson, B. R., Bassell, G. J., & Warren, S. T. (2014) · Human Molecular Genetics

Genetics and Neurodevelopmental DisordersRNA Research and Splicing

Cited by 81

Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.

Raj, N., McEachin, Z. T., Harousseau, W., Zhou, Y., Zhang, F., Merritt-Garza, M. E., Taliaferro, J. M., Kalinowska, M., Marro, S. G., Hales, C. M., et al. (2021) · Cell Reports

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 54

Neurogenetics: Advancing the “Next-Generation” of Brain Research

Zoghbi, H. Y., & Warren, S. T. (2010) · Neuron

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 48

Intragenic probe used for diagnostics in fragile X families

Verkerk, A. J. M. H., De Vries, B. B. A., Niermeijer, M. F., Fu, Y., Nelson, D. L., Warren, S. T., Majoor‐Krakauer, D. F., Halley, D. J. J., & Oostra, B. A. (1992) · American Journal of Medical Genetics

Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases

Cited by 17

Fragile dopamine

Weinshenker, D., & Warren, S. T. (2008) · Nature

Genetics and Neurodevelopmental DisordersNeurotransmitter Receptor Influence on Behavior

Cited by 15